{
    "code": "52027107",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027107",
    "time": "2022-08-12 08:19:56",
    "許可證字號": "衛部藥輸字第027107號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/04\/05",
    "發證日期": "106\/04\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202710702",
    "中文品名": "怡諾肯注射劑",
    "英文品名": "Irinotecan Mylan",
    "適應症": "晚期性大腸直腸癌之第一線治療藥物：\r\n1.與5-FU及folinic acid合併，使用於未曾接受過化學治療之病人。\r\n2.單獨使用於曾接受5-FU療程治療無效之病人。\r\n3.與cetuximab併用，治療曾接受含irinotecan之細胞毒性療法治療失敗且具有上皮生長因子接受體(EGFR)表現型KRAS野生型轉移性大腸直腸癌病人。\r\n4.與5-fluorouracil、folinic acid及bevacizumab合併治療，做為轉移性大腸癌或直腸癌病人的第一線治療藥物。\r\n5.與capecitabine合併治療，做為轉移性大腸直腸癌病人的第一線治療藥物。6.與5-fluorouracil、leucovorin及oxaliplatin合併治療(FOLFIRINOX)，做為轉移性胰臟癌之第一線治療藥物。",
    "劑型": "27D注射液劑",
    "包裝": "2、5毫升玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "IRINOTECAN HYDROCHLORIDE TRIHYDRATE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "6201118216  台灣邁蘭有限公司",
    "申請商地址": "臺北市信義區信義路５段7號27樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIN0921000  MYLAN LABORATORIES LIMITED-OTL",
            "製造廠廠址": "PLOT NO. 284B, BOMMASANDRA-JIGANI LINK ROAD, INDUSTRIAL AREA, ANEKAL TALUK, BANGALORE-560105, INDIA",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200037710",
            "成分名稱": "IRINOTECAN HYDROCHLORIDE TRIHYDRATE",
            "含量描述": "",
            "含量": "0.0200000000",
            "單位": "GM"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Irinotecan Mylan外觀-106-05-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027107&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "怡諾肯注射劑中文仿單-110-11-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027107&Seq=003&Type=9"
        },
        {
            "title": "Irinotecan Mylan外盒標籤-106-05-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027107&Seq=002&Type=8"
        },
        {
            "title": "Irinotecan Mylan中文標籤-106-05-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027107&Seq=001&Type=8"
        }
    ]
}